1 ortality (p = 0.55), and ICU patient disposition (p = 0.
22)
were similar in the two groups.
2 Rates of adverse events of grade 3 or
4 were similar in the two groups (hazard ratio, 1.20; 95% CI, 0
3 The rates of serious adverse events (
AEs)
were similar in the two groups, and no excess mortality from
4 Rates of HIV viral suppression and adherence to
ART were similar in the two groups.
5 Rates of severe and intracranial
bleeding were similar in the two groups in all age groups.
6 The rates of nonintracranial
bleeding were similar in the two groups.
7 Changes in
BP were similar in the two groups (between group difference 1.2
8 muscle, gallbladder, and hepatic adverse effects and
cancer were similar in the two groups.
9 Rates of death from cardiovascular
causes were similar in the two groups.
10 Baseline
characteristics were similar in the two groups.
11 The baseline
characteristics were similar in the two groups.
12 Baseline
characteristics were similar in the two groups; 96.8% of the patients were re
13 Other
characteristics were similar in the two groups.
14 oncomitant drugs administered before and after
chemotherapy were similar in the two groups.
15 ction surgery (54 vs. 221); rates of surgical
complications were similar in the two groups (42% and 38%, respectively).
16 The mean 12-month
costs were similar in the two groups in the cardiac-surgery subgrou
17 severe in-hospital complications including shock and
death were similar in the two groups (P=0.93).
18 Numbers of serious adverse events and
deaths were similar in the two groups, but there were more local rea
19 se events or potential immune-mediated diseases or who
died were similar in the two groups.
20 es of severe adverse events and study-drug
discontinuations were similar in the two groups.
21 The risks of a grade 4
event were similar in the two groups, as were the risks of unschedu
22 Rates of adverse
events were similar in the two groups, although more dose modificati
23 ll rates of hospital readmission and serious adverse
events were similar in the two groups, but neurologic events and sup
24 The incidence and severity of adverse
events were similar in the two groups.
25 The numbers of other serious adverse
events were similar in the two groups.
26 The rates of adverse
events were similar in the two groups.
27 Rates of adverse
events were similar in the two groups.
28 Rates of other neonatal illnesses and adverse
events were similar in the two groups.
29 The frequencies of severe adverse
events were similar in the two groups.
30 Rates of other adverse
events were similar in the two groups.
31 The rates of other adverse
events were similar in the two groups.
32 No deaths occurred; adverse
events were similar in the two groups.
33 Rates of nonhemorrhagic adverse
events were similar in the two groups.
34 The frequency and severity of adverse
events were similar in the two groups.
35 The frequencies of other adverse
events were similar in the two groups.
36 Proxy symptoms of relevance to suicide
ideation were similar in the two groups.
37 roviral resistance among women who acquired HIV-1
infection were similar in the two groups.
38 The causes of graft loss and patient
mortality were similar in the two groups, and were not alcohol-related
39 The rates of grade 3 or 4 peripheral
neuropathy were similar in the two groups.
40 ut previously reported adverse pregnancy and birth
outcomes were similar in the two groups.
41 0.05), whereas in the transthoracic-access cohort,
outcomes were similar in the two groups.
42 Adverse events, anthropometry, mood, and
pain were similar in the two groups.
43 ates of adjudicated cases of acute and chronic
pancreatitis were similar in the two groups (acute pancreatitis, 0.3% in t
44 All biochemical
parameters were similar in the two groups apart from the definite differ
45 Adverse-event
profiles were similar in the two groups.
46 The rates of moderate disability and good
recovery were similar in the two groups.
47 uration and Parkinson disease functional and staging
scores were similar in the two groups with parkinsonism, as was stri
48 electivity, but that speed tuning and direction
selectivity were similar in the two groups.
49 Reductions in incidence over
time were similar in the two groups, a finding that suggests an ef
50 The changes in glycated hemoglobin
values were similar in the two groups.